Project Updates and Milestones news (page 5)

• 

  31 March 2026

  Mesabi Metallics secures $520M Breakwall financing to advance U.S. DR iron-ore project

  Northern Minnesota DR-grade iron ore mine and pellet plant on 16,000+ acres progressing toward commercial start; $2.5B project, 750+ construction workers onsite, backed by EXIM support.
• 

  31 March 2026

  Kemira completes first US full-scale trial of chlorine-free KemConnect DEX

  Trial with Capital Region Water shows a performic-acid, chlorine-free treatment cut bacteria rapidly at low doses, auto-degraded to biodegradable compounds and auto-adjusted dosing.
• 

  31 March 2026

  LanzaTech Q4 & FY2025 Financial Results

  Closed $20M private placement; awarded €40M EU grant; completed LanzaJet share transfers (peak 53%, later ~46% after Series A); revenue $55.8M; net loss $49M; opex -21%
• 

  31 March 2026

  OMV and XRG form Borouge International

  Merger of Borouge, Borealis and NOVA creates global pure‑play polyolefins leader with 13.6 Mtpa capacity, >$500M synergies, advantaged feedstock and investment‑grade ratings
• 

  31 March 2026

  Johnson Matthey DPFi DPF earns Canadian CSA certification

  Electrically regenerating diesel particulate filter certified by CSA for Canadian underground mining/tunnelling; also certified by Canmet and VERT and approved by US MSHA.
• 

  31 March 2026

  Umicore opens Shanghai innovation center

  New 3,600 sqm Shanghai innovation center, first corporate R&D outside Europe; focuses on fuel cells and recycling, expanding to catalysis for renewables, CO2 capture, H2, and local partnerships.

• 

  31 March 2026

  Topsoe signs FEED deal with Hynfra for Jordan green ammonia

  FEED underway for Jordan green ammonia: synthesis tech will convert green H2 to ammonia, avoiding >200,000 t CO2e/yr. FID expected 2027; plant to start 2030; exports planned.
• 

  30 March 2026

  Golden Pass LNG (QatarEnergy/ExxonMobil) achieves first LNG production

  First LNG produced from Train 1 of the 18 mtpa Sabine Pass project, enabling sustained liquefaction and paving way for first cargo and full exports beginning Q2 2026.
• 

  30 March 2026

  Dow’s Carbon Footprint Ledger wins 2026 CIO 100 Award

  Recognized for enabling verifiable PCF certificates, optimizing low‑GHG production pathways, and integrating supply‑chain, sustainability and finance data to scale trusted low‑carbon product offerings.
• 

  30 March 2026

  Merck enlicitide decanoate, an oral PCSK9 inhibitor, reduces LDL‑C more than guideline non‑statins at 8 weeks

  Phase 3 CORALreef AddOn: enlicitide lowered LDL‑C 64.6% at 8 weeks; 78.2% achieved ≥50% reduction and LDL‑C <55 mg/dL; safety comparable to oral non‑statins; FDA CNPV awarded
• 

  30 March 2026

  LKAB raises mineral resources by 900 million tonnes to 7.2 billion tonnes

  Exploration added volume and confidence; reserves ~0.9 Gt. Resources grew mainly at Malmberget; Per Geijer hosts 2.2 Mt REO in situ and phosphorus. EU strategic status granted.
• 

  30 March 2026

  Velocys and SuMo commission Fischer–Tropsch unit at Wednesbury for UK waste-to-SAF

  FT unit at Wednesbury is online and stable, validating integration of gasification and FT for waste-to-SAF and supporting ClearSkies demonstration toward modular, scalable SAF production.
• 

  30 March 2026

  Iberdrola awards €3.5bn contracts for Eastern Green Link 4 HVDC subsea interconnector

  Contracts awarded for a 640 km HVDC subsea link (2,000 MW) between Scotland and England, supplying 1.5M+ homes; construction starts 2028, commissioning 2033; part of wider UK grid investment.
• 

  30 March 2026

  TotalEnergies completes UK North Sea merger with NEO NEXT

  Merger completed; combined group renamed; one party holds a 47.5% stake. It becomes the largest independent producer on the UK Continental Shelf, with 2026 output >250,000 boe/d.
• 

  30 March 2026

  Itabus fleet adopts Enilive HVO

  Entire 100-vehicle fleet runs on HVO made from waste, cutting CO2eq by 79.5%. In 2025 it logged 20M km, used over 3M L HVO (53% avg, 75% peak in Dec).
• 

  30 March 2026

  UBE obtains food-contact approval for UBECycle recycled PE/PA films

  Accredited migration testing plus RecyClass‑certified recycling (following Paulowsky acquisition) confirm regulatory compliance and open use of mechanically recycled PE/PA in regulated packaging.
• 

  30 March 2026

  GSK's bepirovirsen accepted for regulatory review in China for chronic hepatitis B

  China NMPA accepted NDA for bepirovirsen after Phase III B-Well trials showed significant functional cure rates in treated CHB patients; granted Breakthrough Therapy; acceptable safety.
• 

  30 March 2026

  GSK’s Exdensur approved in China for severe eosinophilic asthma

  First ultra-long-acting IL-5 biologic for eosinophilic severe asthma; twice-yearly dosing cut annual exacerbations by ~48–58% in SWIFT trials and lowered hospital/ED visits.
• 

  29 March 2026

  LOTTE Chemical to merge with HD Hyundai Chemical after Daesan spin-off, pivots to specialty materials

  Targets >60% specialty by 2030; building a 500k t/yr compounding plant; creating hydrogen value chain—four fuel-cell plants (80MW) and 450‑bar H2 hub; expanding high-end copper foil and TMAH output.
• 

  29 March 2026

  Merck: WINREVAIR Phase 2 CADENCE shows proof‑of‑concept in CpcPH‑HFpEF

  Met primary endpoint with significant PVR reduction at 24 weeks vs placebo. Also favorable mPAP/PAWP, NT‑proBNP and 6MWD trends, delayed clinical worsening; safety consistent with known profile.
• 

  28 March 2026

  Amgen: Repatha cuts first major cardiovascular events 31% in high‑risk patients without significant atherosclerosis

  VESALIUS‑CV subgroup (3,655 high‑risk diabetics without known atherosclerosis) showed a 31% reduction in first major CV events vs placebo; median LDL‑C 44 mg/dL over ~4.8 years.
• 

  28 March 2026

  Takeda’s Zasocitinib: Once‑daily pill achieves rapid, durable clearance in plaque psoriasis

  Phase 3: ~70% reached sPGA 0/1 at week 16; PASI90 up to 61%, PASI100 up to 33%. Responses rose through week 24 and >90% of responders maintained effect to week 60. Safety consistent with prior studies
• 

  28 March 2026

  Johnson & Johnson STEMI-DTU RCT: LV unloading with delayed reperfusion does not increase infarct size

  Neutral trial. 30‑min Impella improved pre‑PCI TIMI flow. Age 61+ trended smaller infarcts. More bleeding/vascular events but no higher 12‑month mortality. Elevated lactate predicted larger infarcts.
• 

  28 March 2026

  Johnson & Johnson: ICOTYDE (icotrokinra) 52‑week data show sustained skin clearance and favorable safety

  ICONIC Phase 3: PASI100 rose to 49%/48% (ADVANCE 1/2) by Week52; placebo switchers matched. Adolescents: 57% PASI100, 86% PASI90 at 52w. No new safety signals; fewer AEs vs deucravacitinib.
• 

  28 March 2026

  Lilly: Taltz + Zepbound superior to Taltz alone in psoriatic arthritis with obesity

  Phase 3b TOGETHER‑PsA: combination therapy improved ACR50, MDA, fatigue, function, QoL and cardiometabolic markers; 36‑week primary endpoint met (ACR50+≥10% weight loss 31.7% vs 0.8%).
• 

  27 March 2026

  EMA recommends Amgen’s Imdylltra for relapsed extensive‑stage SCLC

  EMA backs EU approval for a bispecific T‑cell engager for relapsed extensive‑stage SCLC post‑platinum; phase 3: OS 13.6 vs 8.3 months. Main risks: CRS, ICANS
• 

  27 March 2026

  Sasol — Middle East developments and business impact

  Middle East conflict disrupted gas supply - ORYX GTL shut; ~60 staff safe. Fuel and chemicals impacted; Secunda/Natref secure inventories and alternative crude; contingencies active.
• 

  27 March 2026

  Lilly's EBGLYSS: durable 4‑year control in moderate‑to‑severe atopic dermatitis

  Up to four years of monthly maintenance produced durable skin clearance (EASI‑75 94%, EASI‑90 75%, IGA 0/1 68%), itch relief (Pruritus NRS≤4: 78%), 80% without topical steroids; safety consistent.
• 

  27 March 2026

  Rompetrol Rafinare completes Petromidia and Vega turnarounds

  Mechanical works finished; refineries return to staged full capacity after 700+ maintenance jobs, 6 catalyst swaps, ~900 equipment checks and ~1,200 pipeline tests; authorizations recertified.
• 

  27 March 2026

  Iberdrola/ScottishPower advances 960 MW East Anglia TWO offshore wind project

  €4.5bn project progressing; offshore substation foundations in production; visited by UK Energy Secretary. Will power nearly 1 million homes and support skilled jobs.